Doxazosin Tablet
Product Images NDC 68084-862

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 68084-862). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1mg 100ud Carton

This is a description of medication called Doxazosin. Tablets are available in a bottle containing 100 tablets in total. Each tablet contains Doxazosin mesylate equivalent to 1 mg doxazosin. Pharmacists need to dispense these tablets with accompanying patient information leaflet. The recommended usual dosage of this medication is mentioned on the package insert. It is essential to store the medication between 15 and 30 degrees Celsius. The packaging includes a code that may help in identifying the specific drug product. This medication is distributed by American Health Packaging in Ohio.*

FDA Label Image

1mg 10ud Blister

FDA Label Image

1mg 30ud Carton

This is a description of a drug called doxazosin. It comes in a package with 30 tablets in 5x6 packaging that should be stored at 20° to 25°C (68° to 77°F) and out of reach of children. The dosage should be read from the package insert. It has the NDC code 68084-836-25 and pharmacist should dispense it with accompanying patient information leaflet to each patient. The drug is manufactured by Apotex Corp and distributed by American Health Packaging in Columbus, Ohio.*

FDA Label Image

1mg 6ud Blister

FDA Label Image

2mg 100ud Carton

This is a medication called Doxazosin which comes as 100 tablets (10x10). Each tablet contains Doxazosin mesylate equivalent to 2 mg Doxazosin. The usual dosage should be checked from the package insert. It should be stored between 20°C to 25°C (68°F to 77°F) and must be kept out of reach of children. Do not use if the blister is torn or broken. The drug product is from DG # 60505-0084, Apotex Corp. and distributed by American Health Packaging out of Columbus, Ohio.*

FDA Label Image

2mg 10ud Blister

Doxazosin is a medication available in varying dosages (from 2mg to 8mg) and forms (tablets such as Doxazosin Tobet, Doxazosin Tabit, and Doxazosin Tadlel) used for treatment purposes.*

FDA Label Image

2mg 30ud Carton

This is a description of a drug called Doxazosin in a tablet form. The drug comes in a package of 30 tablets with each tablet containing Doxazosin mesylate equivalent to 2 mg doxazosin. It has a stored temperature of 20 to 25°C and is to be kept out of reach of children. The package must not be used if the blister is torn or broken. The drug product is distributed by American Health Packaging in Columbus, Ohio.*

FDA Label Image

2mg 6ud Blister

FDA Label Image

4 mg 6ud Blister

FDA Label Image

4mg 100ud Carton

This is the description of a drug product called Doxazosin. It contains a tablet of Doxazosin mesylate equivalent to 4 mg Doxazosin. This medication is for prescription only and should be taken as per the instructions provided in the package insert. It is advised to store it at a temperature between 20° to 25°C and to keep it away from the reach of children. The product is manufactured by Apotex Corp and distributed by American Health Packaging in Columbus, Ohio. It is recommended to dispense along with the accompanying patient information leaflet.*

FDA Label Image

4mg 10ud Blister

Doxazosin is a medication available in tablet form. Its use is not entirely clear given the garbled text.*

FDA Label Image

4mg 30ud Carton

This is a description of a medication with the NDC code 68084-862-25. The medication is Doxazosin tablets, available only on prescription. The pack contains 30 tablets (5 x 6). Each tablet contains Doxazosin mesylate equivalent to 4 mg doxazosin. The packaging should include Patient Information Leaflet to each patient. The package should be stored between 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). However, the description doesn't provide any further information about the medication's use or the health condition it treats.*

FDA Label Image

Ahp83601

FDA Label Image

Ahp85101

FDA Label Image

Ahp86201

FDA Label Image

Figure1.jpg (Figure1)

FDA Label Image

Structure

FDA Label Image

Table3.jpg (Table3)

The provided text appears to be a table showing the results of three placebo-controlled trials evaluating the effectiveness of doxazosin in patients with benign prostatic hyperplasia (BPH). The table lists the maximum flow rate, symptom score, and rates of change in these measures before and after treatment with either doxazosin or placebo. It also includes details about the dosing regimens for each study and the statistical significance of the results. Therefore, the text can be described as a summary of the results of the trials evaluating the effectiveness of doxazosin in treating BPH.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.